Results 231 to 240 of about 292,375 (262)
Some of the next articles are maybe not open access.
Acta Medica Mediterranea, 2022
<p style="text-align:justify;font-size:9px;font-family:Times;"><b><i>Objectives</i></b><i>: D-dimer is increasingly becoming an important auxiliary marker in guiding diagnosis and treatment in various fields of medicine.
openaire +1 more source
<p style="text-align:justify;font-size:9px;font-family:Times;"><b><i>Objectives</i></b><i>: D-dimer is increasingly becoming an important auxiliary marker in guiding diagnosis and treatment in various fields of medicine.
openaire +1 more source
Comparison of D-Dimer PLUS assay with NycoCard D-Dimer
Thrombosis and haemostasis, 2003Measurement of D-dimer levels has gained widespread use in the diagnosis of various clinical situations that relate to thrombosis and fibrinolysis. Nowadays, different rapid and fully automated quantitative D-Dimer assays that can be performed on coagulation analyzers are commercially available.
Zadro, Renata, Coen Herak, Desiree
openaire +2 more sources
D-dimer – a multifaceted molecule
Hormone Molecular Biology and Clinical InvestigationAbstract D-dimer, a universally unique marker for fibrin degradation, is generated through the enzymatic interplay of thrombin, factor XIIIa, and plasmin. The emergence of D-dimer-containing fibrin molecules occurs in both intravascular and extravascular spaces during pivotal physiological processes like haemostasis, thrombosis, and ...
Devika Tayal +2 more
openaire +2 more sources
D-Dimer in Venous Thromboembolism
New England Journal of Medicine, 2003Venous thromboembolism is an important medical problem, with an estimated incidence in the United States of 100,000 to 300,000 cases per year. Of patients presenting with symptoms suggestive of deep venous thrombosis, only 30 percent actually have the disorder.
openaire +2 more sources
Advances in clinical chemistry, 2023
D-dimer containing species are soluble fibrin degradation products derived from plasmin-mediated degradation of cross-linked fibrin, i.e., 'D-dimer'. D-dimer can hence be considered a biomarker of in vivo activation of both coagulation and fibrinolysis, the leading clinical application in daily practice of which is ruling out venous thromboembolism ...
Wauthier, L +11 more
openaire +1 more source
D-dimer containing species are soluble fibrin degradation products derived from plasmin-mediated degradation of cross-linked fibrin, i.e., 'D-dimer'. D-dimer can hence be considered a biomarker of in vivo activation of both coagulation and fibrinolysis, the leading clinical application in daily practice of which is ruling out venous thromboembolism ...
Wauthier, L +11 more
openaire +1 more source
Long- and short-term in vitro D-dimer stability measured with INNOVANCE D-Dimer
Thrombosis and Haemostasis, 2010Summary In vitro D-dimer stability in plasma is widely assumed, but has not yet been documented by systematic studies using samples covering a wide range of D-dimer. We investigated the short- and long-term stability of D-dimer in clinical citrated plasma samples with normal and pathological levels.
M, Böhm-Weigert +4 more
openaire +2 more sources
Thrombosis Research, 2005
The objective of this study was to evaluate if D-Dimer PLUS (Dade Behring, USA), a rapid fully automated assay, could be used as an initial screening test in the diagnosis of venous thromboembolism (VTE). Samples from 274 consecutive symptomatic patients with suspected pulmonary embolism (n=229; 79% outpatients, 21% inpatients), deep venous thrombosis (
H J, Vermeer +7 more
openaire +2 more sources
The objective of this study was to evaluate if D-Dimer PLUS (Dade Behring, USA), a rapid fully automated assay, could be used as an initial screening test in the diagnosis of venous thromboembolism (VTE). Samples from 274 consecutive symptomatic patients with suspected pulmonary embolism (n=229; 79% outpatients, 21% inpatients), deep venous thrombosis (
H J, Vermeer +7 more
openaire +2 more sources
Thrombosis Research, 2009
D-dimer assays are now widely used as the first-line test in the diagnostic algorithm of suspected deep vein thrombosis (DVT). The aim of this study was to evaluate the performance of two relatively new quantitative D-Dimer assays (Innovance and AxSYM) by comparison with a clinical gold standard.311 samples from outpatients with clinical suspicion of ...
J L, Elf, K, Strandberg, P J, Svensson
openaire +2 more sources
D-dimer assays are now widely used as the first-line test in the diagnostic algorithm of suspected deep vein thrombosis (DVT). The aim of this study was to evaluate the performance of two relatively new quantitative D-Dimer assays (Innovance and AxSYM) by comparison with a clinical gold standard.311 samples from outpatients with clinical suspicion of ...
J L, Elf, K, Strandberg, P J, Svensson
openaire +2 more sources
2010
Die D-Dimer-Bestimmung hat einen gesicherten Stellenwert in der Diagnostik der venosen Thrombose und der Lungenembolie. Verfahren zur D-Dimer-Bestimmung werden in verschiedenen Testkonfigurationen angeboten. Die beste diagnostische Sensitivitat wird mit ELISA-Verfahren erreicht.
K. Madlener, B. Pötzsch
openaire +1 more source
Die D-Dimer-Bestimmung hat einen gesicherten Stellenwert in der Diagnostik der venosen Thrombose und der Lungenembolie. Verfahren zur D-Dimer-Bestimmung werden in verschiedenen Testkonfigurationen angeboten. Die beste diagnostische Sensitivitat wird mit ELISA-Verfahren erreicht.
K. Madlener, B. Pötzsch
openaire +1 more source

